Protein folding activity of the ribosome (PFAR) — A target for antiprion compounds

Viruses

Volumn 6, Issue 10, 2014, Pages 3907-3924

  Banerjee, Debapriya ^a   Sanyal, Suparna ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

23S rRNA; Amyloid; Antiprion compounds; Domain V; PFAR; Prion; Protein folding; Ribosomal RNA; Ribosome

Indexed keywords

6 AMINOPHENANTHRIDINE; AMODIAQUINE; AMYLOID; ANTIPRION COMPOUND; AROMATIC COMPOUND; CARBONATE DEHYDRATASE; CHLOROQUINE; CHLORPROMAZINE; CYCLOBENZAPRINE; DOMINE V RRNA; GUANABENZ ACETATE; GUANABENZENE; IMIDAZOQUINOLINE DERIVATIVE; IMIQUIMOD; KASTELLPAOLITINE; PEPTIDES AND PROTEINS; PHENANTHRIDINE DERIVATIVE; PRION PROTEIN; PROTEIN INHIBITOR; PROTEINASE K; RIBOSOME RNA; RNA 23S; RNA 25S; RNA 28S; SUP35 PROTEIN; UNCLASSIFIED DRUG; URE2 PROTEIN; 6-AMINOPHENANTHRIDINE; AMINOQUINOLINE DERIVATIVE; GUANABENZ; PRION;

BINDING SITE; COLORIMETRY; COMPETITIVE INHIBITION; DENSITY FUNCTIONAL THEORY; ENTAMOEBA COLI; FLUORESCENCE ANALYSIS; HEALTH HAZARD; HUMAN; NEUROBLASTOMA; NONHUMAN; PRION DISEASE; PROTEIN BINDING; PROTEIN BINDING SITE; PROTEIN DETERMINATION; PROTEIN FOLDING; REVIEW; RIBOSOME; SACCHAROMYCES CEREVISIAE; YEAST PRION BASED ASSAY; CHEMISTRY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; PRION; PRION DISEASES;

AMINOQUINOLINES; BINDING SITES; GUANABENZ; HUMANS; PHENANTHRIDINES; PRION DISEASES; PRIONS; PROTEIN FOLDING; RIBOSOMES; RNA, RIBOSOMAL;

EID: 84908245287     PISSN: 19994915     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v6103907     Document Type: Review

References (46)

1. Prusiner, S.B. Molecular biology of prion diseases. Science 1991, 252, 1515-1522.
2. Prusiner, S.B. Prions. Proc. Natl. Acad. Sci. USA 1998, 95, 13363-13383.
3. Weissmann, C.; Aguzzi, A. Approaches to therapy of prion diseases. Annu. Rev. Med. 2005, 56, 321-344.
4. Riek, R.; Hornemann, S.; Wider, G.; Glockshuber, R.; Wüthrich, K. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 1997, 413, 282-288.
5. Tycko, R.; Savtchenko, R.; Ostapchenko, V.G.; Makarava, N.; Baskakov, I.V. The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: Evidence from solid state nuclear magnetic resonance. Biochemistry 2010, 49, 9488-9497.
6. Jarrett, J.T.; Lansbury, P.T., Jr. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 1993, 73, 1055-1058.
7. Collinge, J.; Clarke, A.R. A general model of prion strains and their pathogenicity. Science 2007, 318, 930-936.
8. Deleault, N.R.; Lucassen, R.W.; Supattapone, S. RNA molecules stimulate prion protein conversion. Nature 2003, 425, 717-720.
9. Cordeiro, Y.; Machado, F.; Juliano, L.; Juliano, M.A.; Brentani, R.R.; Foguel, D.; Silva, J.L. DNA converts cellular prion protein into the β-sheet conformation and inhibits prion peptide aggregation. J. Biol. Chem. 2001, 276, 49400-49409.
10. Gomes, M.P.B.; Cordeiro, Y.; Silva, J.L. The peculiar interaction between mammalian prion protein and RNA. Prion 2008, 2, 64-66.
11. Macedo, B.; Millen, T.A.; Braga, C.A.C.A.; Gomes, M.P.B.; Ferreira, P.S.; Kraineva, J.; Winter, R.; Silva, J.L.; Cordeiro, Y. Nonspecific prion protein-nucleic acid interactions lead to different aggregates and cytotoxic species. Biochemistry 2012, 51, 5402-5413.
12. Silva, J.L.; Lima, L.M.; Foguel, D.; Cordeiro, Y. Intriguing nucleic-acid-binding features of mammalian prion protein. Trends Biochem. Sci. 2008, 33, 132-140.
13. Cordeiro, Y.; Lima, L.M.; Gomes, M.P.; Foguel, D.; Silva, J.L. Modulation of prion protein oligomerization, aggregation, and beta-sheet conversion by 4,4'-dianilino-1,1'-binaphthyl-5,5'-sulfonate (bis-ANS). J. Biol. Chem. 2004, 279, 5346-5352.
14. Gomes, M.P.; Vieira, T.C.; Cordeiro, Y.; Silva, J.L. The role of RNA in mammalian prion protein conversion. Wiley Interdiscipl. Rev. RNA 2012, 3, 415-428.
15. McKinley, M.P.; Bolton, D.C.; Prusiner, S.B. A protease-resistant protein is a structural component of the Scrapie prion. Cell 1983, 35, 57-62.
16. Meyer, R.K.; McKinley, M.P.; Bowman, K.A.; Braunfeld, M.B.; Barry, R.A.; Prusiner, S.B. Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. USA 1986, 83, 2310-2314.
17. Korth, C.; May, B.C.H.; Cohen, F.E.; Prusiner, S.B. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci. USA 2001, 98, 9836-9841.
18. Kocisko, D.A.; Baron, G.S.; Rubenstein, R.; Chen, J.; Kuizon, S.; Caughey, B. New Inhibitors of Scrapie-Associated Prion Protein Formation in a Library of 2000 Drugs and Natural Products. J. Virol. 2003, 77, 10288-10294.
19. Bertsch, U.; Winklhofer, K.F.; Hirschberger, T.; Bieschke, J.; Weber, P.; Hartl, F.U.; Tavan, P.; Tatzelt, J.; Kretzschmar, H.A.; Giese, A. systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets. J. Virol. 2005, 79, 7785-7791.
20. Bach, S.; Talarek, N.; Andrieu, T.; Vierfond, J.-M.; Mettey, Y.; Galons, H.; Dormont, D.; Meijer, L.; Cullin, C.; Blondel, M. Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nat. Biotechnol. 2003, 21, 1075-1081.
21. Bach, S.; Tribouillard, D.; Talarek, N.; Desban, N.; Gug, F.; Galons, H.; Blondel, M. A yeast-based assay to isolate drugs active against mammalian prions. Methods 2006, 39, 72-77.
22. Tribouillard-Tanvier, D.; Béringue, V.; Desban, N.; Gug, F.; Bach, S.; Voisset, C.; Galons, H.; Laude, H.; Vilette, D.; Blondel, M. Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions. PLoS One 2008, 3, E1981.
23. Oumata N; Nguyen Ph; Beringue V; Soubigou F.Y. P.; Desban, N.; Massacrier, C.; Morel, Y.; Paturel, C.; Contesse, M.A., et al. The toll-like receptor agonist Imiquimod is active against prions. PLoS One 2013, 8, e72112.
24. Tribouillard-Tanvier, D.; Dos Reis, S.; Gug, F.; Voisset, C.; Beringue, V.; Sabate, R.; Kikovska, E.; Talarek, N.; Bach, S.; Huang, C., et al. Protein folding activity of ribosomal RNA Is a selective target of two unrelated antiprion drugs. PLoS One 2008, 3, e2174.
25. Gug, F.; Oumata, N.; Tribouillard-Tanvier, D.; Voisset, C.; Desban, N.; Bach, S.; Blondel, M.; Galons, H. Synthesis of conjugates of 6-Aminophenanthridine and guanabenz, two structurally unrelated prion inhibitors, for the determination of their cellular targets by affinity chromatography. Bioconjug. Chem. 2010, 21, 279-288.
26. Das, D.; Das, A.; Samanta, D.; Ghosh, J.; Dasgupta, S.; Bhattacharya, A.; Basu, A.; Sanyal, S.; Dasgupta, C. Role of the ribosome in protein folding. Biotech. J. 2008, 3, 999-1009.
27. Voisset, C.; Saupe, S.J.; Blondel, M. The various facets of the protein-folding activity of the ribosome. Biotech J. 2011, 6, 668-673.
28. Kudlicki, W.; Coffman, A.; Kramer, G.; Hardesty, B. Ribosomes and ribosomal RNA as chaperones for folding of proteins. Fold Des. 1997, 2, 101-108.
29. Das, B.; Gupta, C.D. Reconstitution of denatured E. coli alkaline phosphatase with E. coli ribosome. Indian J. Biochem. Biol. 1992, 29, 512-515.
30. Das, B.; Chattopadhyay, S.; Das Gupta, C. Reactivation of denatured fungal glucose 6-phosphate dehydrogenase and E. coli alkaline phosphatase with E. coli ribosome. Biochem. Bioph. Res. Co. 1992, 183, 774-780.
31. Argent, R.H.; Parrott, A.M.; Day, P.J.; Roberts, L.M.; Stockley, P.G.; Lord, J.M.; Radford, S.E. Ribosome-mediated folding of partially unfolded ricin A-chain. J. Biol. Chem. 2000, 275, 9263-9269.
32. Das, B.; Chattopadhyay, S.; Bera, A.K.; Dasgupta, C. In vitro protein folding by ribosomes from Escherichia coli, wheat germ and rat liver. Eur. J. Biochem. 1996, 235, 613-621.
33. Sanyal, S.C.; Pal, S.; Chaudhuri, S.; Dasgupta, C. 23S rRNA assisted folding of cytoplasmic malate dehydrogenase is distinctly different from its self-folding. Nucleic Acids Res. 2002, 30, 2390-2397.
34. Bera, A.K.; Das, B.; Chattopadhyay, S.; Dasgupta, C. Refolding of denatured restriction endonucleases with ribosomal preparations from Methanosarcina barkeri. Biochem. Mol. Biol. Int. 1994, 32, 315-323.
35. Chattopadhyay, S.; Das, B.; Bera, A.K.; Dasgupta, D.; Dasgupta, C. Refolding of denatured lactate dehydrogenase by Escherichia coli ribosomes. Biochem. J. 1994, 300, 717-721.
36. Chattopadhyay, S.; Das, B.; Dasgupta, C. Reactivation of denatured proteins by 23S ribosomal RNA: Role of domain V. Proc. Natl. Acad. Sci. USA 1996, 93, 8284-8287.
37. Pal, D.; Chattopadhyay, S.; Chandra, S.; Sarkar, D.; Chakraborty, A.; Dasgupta, C. Reactivation of denatured proteins by domain V of bacterial 23S rRNA. Nucleic Acids Res. 1997, 25, 5047-5051.
38. Pal, S.; Chandra, S.; Chowdhury, S.; Sarkar, D.; Ghosh, A.N.; Gupta, C.D. Complementary role of two fragments of domain V of 23 s ribosomal RNA in protein folding. J. Biol. Chem. 1999, 274, 32771-32777.
39. Samanta, D.; Mukhopadhyay, D.; Chowdhury, S.; Ghosh, J.; Pal, S.; Basu, A.; Bhattacharya, A.; Das, A.; Das, D.; DasGupta, C. Protein folding by domain V of Escherichia coli 23S rRNA: Specificity of RNA-protein interactions. J. Bacteriol. 2008, 190, 3344-3352.
40. Ban, N.; Nissen, P.; Hansen, J.; Moore, P.B.; Steitz, T.A. The complete atomic structure of the large ribosomal subunit at 2.4 Å resolution. Science 2000, 289, 905-920.
41. Basu, A.; Samanta, D.; Das, D.; Chowdhury, S.; Bhattacharya, A.; Ghosh, J.; Das, A.; DasGupta, C. In vitro protein folding by E. coli ribosome: Unfolded protein splitting 70S to interact with 50S subunit. Biochem. Biophys. Res. Comm. 2008, 366, 598-603.
42. Mondal S; Pathak BK; Ray S.C.B. Impact of P-site tRNA and antibiotics on ribosome mediated protein folding: studies using the Escherichia coli ribosome. PLoS One 2014, 9, e101293.
43. Ghosh, J.; Basu, A.; Pal, S.; Chowdhuri, S.; Bhattacharya, A.; Pal, D.; Chattoraj, D.K.; DasGupta, C. Ribosome-DnaK interactions in relation to protein folding. Mol. Microbiol. 2003, 48, 1679-1692.
44. Reis, S.D.; Pang, Y.; Vishnu, N.; Voisset, C.; Galons, H.; Blondel, M.; Sanyal, S. Mode of action of the antiprion drugs 6AP and GA on ribosome assisted protein folding. Biochimie 2011, 93, 1047-1054.
45. Banerjee, D.; Vovusha, H.; Pang, Y.; Oumata, N.; Sanyal, B.; Sanyal, S. Spectroscopic and DFT studies on 6-Aminophenanthridine and its derivatives provide insights in their activity towards ribosomal RNA. Biochimie 2014, 97, 194-199.
46. Pang, Y.; Kurella, S.; Voisset, C.; Samanta, D.; Banerjee, D.; Schabe, A.; Dasgupta, C.; Galons, H.; Blondel, M.; Sanyal, S. The antiprion compound 6-Aminophenanthridine inhibits protein folding activity of the ribosome by direct competition. J. Biol. Chem. 2013, 288 19081-19089.